A Community-based, Behavioral Intervention to Improve Screening for Hepatitis C Among High-risk Young Adults in Wisconsin
Hep-Net
1 other identifier
interventional
235
0 countries
N/A
Brief Summary
The goal of this study is to evaluate the effectiveness of a brief, computerized behavioral intervention for promoting screening for hepatitis C and reducing risky behavior for people who inject drugs (PWID).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2014
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 15, 2015
CompletedFirst Posted
Study publicly available on registry
June 17, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2016
CompletedJanuary 11, 2019
January 1, 2019
2 years
June 15, 2015
January 9, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Screening for hepatitis C infection
Participants will be followed for 12 months to determine whether they undergo repeated screening for hepatitis C
12 months
Study Arms (2)
Usual care
ACTIVE COMPARATORStandard health education and prevention counseling by trained staff
Hep-Net Intervention
EXPERIMENTALComputerized tailored behavioral intervention
Interventions
The Hep-Net Intervention is a web-based questionnaire and tailored feedback system designed to increase readiness to change with respect to several behaviors. The behaviors include (1) reducing or quitting drug use; (2) using sterile equipment every time one injects drugs; (3) undergoing screening for hepatitis C; (4) receiving training to use naloxone to prevent death due to opioid overdose.
Clients receive health education and risk reduction counseling from a trained prevention specialist.
Eligibility Criteria
You may qualify if:
- Age 18 or over
- English-speaking
- Reports injection of illicit drugs in the past month
You may not qualify if:
- Unable to provide informed consent due to cognitive impairment
- Unwilling to provide personal locator information and consent to be contacted for follow-up after 3 months.
- Currently known to be pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Hochstatter KR, Hull SJ, Sethi AK, Burns ME, Mundt MP, Westergaard RP. Promoting Safe Injection Practices, Substance Use Reduction, Hepatitis C Testing, and Overdose Prevention Among Syringe Service Program Clients Using a Computer-Tailored Intervention: Pilot Randomized Controlled Trial. J Med Internet Res. 2020 Sep 29;22(9):e19703. doi: 10.2196/19703.
PMID: 32990630DERIVEDWestergaard RP, Hull SJ, Merkow A, Stephens LK, Hochstatter KR, Olson-Streed HK, Baker LM, Hess TM. Computerized Tailored Interventions to Enhance Prevention and Screening for Hepatitis C Virus Among People Who Inject Drugs: Protocol for a Randomized Pilot Study. JMIR Res Protoc. 2016 Jan 22;5(1):e15. doi: 10.2196/resprot.4830.
PMID: 26800903DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ryan Westergaard, MD, PhD
University of Wisconsin, Madison
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 15, 2015
First Posted
June 17, 2015
Study Start
August 1, 2014
Primary Completion
August 1, 2016
Study Completion
August 1, 2016
Last Updated
January 11, 2019
Record last verified: 2019-01